The FOxTROT trial - Fluoropyrimidine, Oxaliplatin and Targeted Receptor pre-Operative Therapy for high risk colon cancer
Click on link below for an overview of the trial.
This trial was developed by the NCRI Colorectal Cancer Study Group and is funded by Cancer Research UK.
If you or your centre would like to participate contact the study co-ordinator, Dr Laura Magill, at Birmingham Clinical Trials Unit.
Tel: 0121 415 9105
This page was last updated on 14-10-2009